Michael Barbella, Managing Editor03.16.23
H.B. Fuller has debuted the biocompatible Swift melt 1515-I in India, Middle East, and Africa (IMEA). The product, for microporous medical tape applications, is designed to be used in stick-to-skin under unique climatic conditions, such as the high temperatures and humidity in the Indian sub-continent.
“This is a breakthrough from our H.B. Fuller’s R&D team in India, which has developed this new technology in our lab in Pune, in response to the IMEA market specifics to support advanced stick-to-skin product compliant for medical use – such as nonwoven surgical,” said Manish Dwivedi, flexible materials, business manager for India. “Globally, our products have been used around the world in medical applications for more than two decades, enabling diverse new ideas and accelerating innovation for this industry.”
Swift melt 1515-I delivers effective high tack, secure and quick bonding, under high temperature and with shear resistance. The product, which shows excellent performance, balancing adhesion and ease of removal, was thoroughly tested and certified by ISO 10993-5 for cytotoxicity. Since it is not toxic to human cells, the adhesive can effectively be used in medical applications in hospitals and home care in stick-to-skin situations.
Population pressure, the growing prevalence of diseases, and the increasing number of surgeries and chronic and traumatic wounds are turning the global medical tapes and bandages market into a profitable one. This segment is expected to reach $8.59 billion by 2026 (globally), $850.1 million of which will be generated in India, according to MarketsandMarkets report, “Medical Tapes and Bandages Market – Global Forecast 2026.”
Swift is a trademark of H.B. Fuller Company or an affiliated company of H.B. Fuller.
Since 1887, H.B. Fuller has been a global adhesives provider focusing on perfecting adhesives, sealants, and other specialty chemical products. Its fiscal 2021 net revenue totaled $3.3 billion.
“This is a breakthrough from our H.B. Fuller’s R&D team in India, which has developed this new technology in our lab in Pune, in response to the IMEA market specifics to support advanced stick-to-skin product compliant for medical use – such as nonwoven surgical,” said Manish Dwivedi, flexible materials, business manager for India. “Globally, our products have been used around the world in medical applications for more than two decades, enabling diverse new ideas and accelerating innovation for this industry.”
Swift melt 1515-I delivers effective high tack, secure and quick bonding, under high temperature and with shear resistance. The product, which shows excellent performance, balancing adhesion and ease of removal, was thoroughly tested and certified by ISO 10993-5 for cytotoxicity. Since it is not toxic to human cells, the adhesive can effectively be used in medical applications in hospitals and home care in stick-to-skin situations.
Population pressure, the growing prevalence of diseases, and the increasing number of surgeries and chronic and traumatic wounds are turning the global medical tapes and bandages market into a profitable one. This segment is expected to reach $8.59 billion by 2026 (globally), $850.1 million of which will be generated in India, according to MarketsandMarkets report, “Medical Tapes and Bandages Market – Global Forecast 2026.”
Swift is a trademark of H.B. Fuller Company or an affiliated company of H.B. Fuller.
Since 1887, H.B. Fuller has been a global adhesives provider focusing on perfecting adhesives, sealants, and other specialty chemical products. Its fiscal 2021 net revenue totaled $3.3 billion.